BlackRock, Inc. 13D and 13G filings for Prometheus Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-03 12:09 pm Purchase | 2022-12-31 | 13G | Prometheus Biosciences, Inc. RXDX | BlackRock Inc. BLK | 2,807,704 6.100% | 918,944 (+48.65%) | Filing |
| 2022-05-09 3:23 pm Sale | 2022-04-30 | 13G | Prometheus Biosciences, Inc. RXDX | BlackRock Inc. BLK | 1,888,760 4.800% | -272,009 (-12.59%) | Filing |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Prometheus Biosciences, Inc. RXDX | BlackRock Inc. BLK | 2,160,769 5.500% | 2,160,769 (New Position) | Filing |